Devices

The FDA cleared The Bigfoot Unity AI Diabetes Management System by Bigfoot Biomedical for T1D & T2D management in patients of 12 or older.  

Continuous glucose monitoring in ICU patients can provide unique benefits to both patients and frontline healthcare workers.

Could adding a SGLT-2 inhibitor to a closed-loop automated insulin delivery reduce the need for carbohydrate counting? 

Continuous glucose monitoring systems can enable pregnant women to monitor blood glucose more effectively. 

I was working with a patient who'd recently had a pump upgrade, and although he said he didn't have problems or issues with infusion set changes, I urged him to change his set while I was present.  In the process, he did very well with filling his reservoir and inserting his infusion set. The problem was noted when he went to the cannula fill amount....

Self-management of diabetes can be more successful when telemonitoring is included.

An interoperable artificial pancreas system smartphone app was designed, developed, and tested to make decision-making algorithms while running on an unlocked smartphone.  An Artificial Pancreas system closes the loop between a continuous glucose monitor (CGM) and an insulin pump by creating an algorithm that adjusts the insulin dose to control blood glucose …

Less than 20% of children with type 1 diabetes attain the target glycated hemoglobin level of less than 7% recommended by the American Diabetes Association.

The first study conducted on this device that explores the effectiveness and safety parameters. 

Patients are relieved to know that care continues through the coronavirus pandemic.